Which hormone drug best halts lobular breast cancer growth?
Disease control
Completed
This phase 2 trial compares three hormone therapies—fulvestrant, anastrozole, and tamoxifen—in women with invasive lobular breast cancer, a subtype that is often treated the same as more common breast cancers despite limited evidence. Participants take one of the drugs for about …
Phase: PHASE2 • Sponsor: Priscilla McAuliffe • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC